 | • レポートコード：GIR-107A12647 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、希少疾患診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。希少疾患診断の種類別市場規模（血液、腫瘍）、用途別市場規模（病院研究所、診断研究所、遺伝子検査研究所、がん研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・希少疾患診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Retrophin、3billion、23andMe、QIAGEN、Illumina、PerkinElmer、Strand Life Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血液、腫瘍 ・用途別分析2016年-2026年：病院研究所、診断研究所、遺伝子検査研究所、がん研究所、その他 ・希少疾患診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・希少疾患診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・希少疾患診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・希少疾患診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・希少疾患診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rare Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rare Disease Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rare Disease Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rare Disease Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hematology
Oncology
Market segment by Application, can be divided into
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Market segment by players, this report covers
Retrophin
3billion
23andMe
QIAGEN
Illumina
PerkinElmer
Strand Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Classification of Rare Disease Diagnostics by Type
1.2.1 Overview: Global Rare Disease Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rare Disease Diagnostics Revenue Market Share by Type in 2020
1.2.3 Hematology
1.2.4 Oncology
1.3 Global Rare Disease Diagnostics Market by Application
1.3.1 Overview: Global Rare Disease Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Global Rare Disease Diagnostics Market Size & Forecast
1.5 Global Rare Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Rare Disease Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rare Disease Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Rare Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Rare Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rare Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Rare Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rare Disease Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rare Disease Diagnostics Market Drivers
1.6.2 Rare Disease Diagnostics Market Restraints
1.6.3 Rare Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Retrophin
2.1.1 Retrophin Details
2.1.2 Retrophin Major Business
2.1.3 Retrophin Rare Disease Diagnostics Product and Solutions
2.1.4 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Retrophin Recent Developments and Future Plans
2.2 3billion
2.2.1 3billion Details
2.2.2 3billion Major Business
2.2.3 3billion Rare Disease Diagnostics Product and Solutions
2.2.4 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 3billion Recent Developments and Future Plans
2.3 23andMe
2.3.1 23andMe Details
2.3.2 23andMe Major Business
2.3.3 23andMe Rare Disease Diagnostics Product and Solutions
2.3.4 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 23andMe Recent Developments and Future Plans
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business
2.4.3 QIAGEN Rare Disease Diagnostics Product and Solutions
2.4.4 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 QIAGEN Recent Developments and Future Plans
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Rare Disease Diagnostics Product and Solutions
2.5.4 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Illumina Recent Developments and Future Plans
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business
2.6.3 PerkinElmer Rare Disease Diagnostics Product and Solutions
2.6.4 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 PerkinElmer Recent Developments and Future Plans
2.7 Strand Life Sciences
2.7.1 Strand Life Sciences Details
2.7.2 Strand Life Sciences Major Business
2.7.3 Strand Life Sciences Rare Disease Diagnostics Product and Solutions
2.7.4 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Strand Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rare Disease Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rare Disease Diagnostics Players Market Share
3.2.2 Top 10 Rare Disease Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Rare Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rare Disease Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Rare Disease Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rare Disease Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Rare Disease Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rare Disease Diagnostics Revenue by Type (2016-2026)
6.2 North America Rare Disease Diagnostics Revenue by Application (2016-2026)
6.3 North America Rare Disease Diagnostics Market Size by Country
6.3.1 North America Rare Disease Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Rare Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Rare Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Rare Disease Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rare Disease Diagnostics Revenue by Type (2016-2026)
7.2 Europe Rare Disease Diagnostics Revenue by Application (2016-2026)
7.3 Europe Rare Disease Diagnostics Market Size by Country
7.3.1 Europe Rare Disease Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Rare Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Rare Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rare Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Rare Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rare Disease Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Rare Disease Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Rare Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Rare Disease Diagnostics Revenue by Region (2016-2026)
8.3.2 China Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rare Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Rare Disease Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rare Disease Diagnostics Revenue by Type (2016-2026)
9.2 South America Rare Disease Diagnostics Revenue by Application (2016-2026)
9.3 South America Rare Disease Diagnostics Market Size by Country
9.3.1 South America Rare Disease Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Rare Disease Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Rare Disease Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rare Disease Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Rare Disease Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Rare Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Rare Disease Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Rare Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rare Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Rare Disease Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Rare Disease Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rare Disease Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rare Disease Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rare Disease Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rare Disease Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Retrophin Corporate Information, Head Office, and Major Competitors
Table 7. Retrophin Major Business
Table 8. Retrophin Rare Disease Diagnostics Product and Solutions
Table 9. Retrophin Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. 3billion Corporate Information, Head Office, and Major Competitors
Table 11. 3billion Major Business
Table 12. 3billion Rare Disease Diagnostics Product and Solutions
Table 13. 3billion Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. 23andMe Corporate Information, Head Office, and Major Competitors
Table 15. 23andMe Major Business
Table 16. 23andMe Rare Disease Diagnostics Product and Solutions
Table 17. 23andMe Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 19. QIAGEN Major Business
Table 20. QIAGEN Rare Disease Diagnostics Product and Solutions
Table 21. QIAGEN Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Illumina Corporate Information, Head Office, and Major Competitors
Table 23. Illumina Major Business
Table 24. Illumina Rare Disease Diagnostics Product and Solutions
Table 25. Illumina Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 27. PerkinElmer Major Business
Table 28. PerkinElmer Rare Disease Diagnostics Product and Solutions
Table 29. PerkinElmer Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Strand Life Sciences Corporate Information, Head Office, and Major Competitors
Table 31. Strand Life Sciences Major Business
Table 32. Strand Life Sciences Rare Disease Diagnostics Product and Solutions
Table 33. Strand Life Sciences Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Rare Disease Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 35. Global Rare Disease Diagnostics Revenue Share by Players (2019-2021)
Table 36. Breakdown of Rare Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Rare Disease Diagnostics Players Head Office, Products and Services Provided
Table 38. Rare Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 39. Rare Disease Diagnostics New Entrants and Expansion Plans
Table 40. Global Rare Disease Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 41. Global Rare Disease Diagnostics Revenue Share by Type (2016-2021)
Table 42. Global Rare Disease Diagnostics Revenue Forecast by Type (2021-2026)
Table 43. Global Rare Disease Diagnostics Revenue by Application (2016-2021)
Table 44. Global Rare Disease Diagnostics Revenue Forecast by Application (2021-2026)
Table 45. North America Rare Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Rare Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Rare Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Rare Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Rare Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Rare Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Rare Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Rare Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Rare Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Rare Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Rare Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Rare Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Rare Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Rare Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Rare Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Rare Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Rare Disease Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Rare Disease Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Rare Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Rare Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Rare Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Rare Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Rare Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Rare Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Rare Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Rare Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Rare Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Rare Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Rare Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Rare Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rare Disease Diagnostics Picture
Figure 2. Global Rare Disease Diagnostics Revenue Market Share by Type in 2020
Figure 3. Hematology
Figure 4. Oncology
Figure 5. Rare Disease Diagnostics Revenue Market Share by Application in 2020
Figure 6. Hospital Laboratories Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Genetic Testing Laboratories Picture
Figure 9. Cancer Research Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Rare Disease Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Rare Disease Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Rare Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 14. Global Rare Disease Diagnostics Revenue Market Share by Region in 2020
Figure 15. North America Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Rare Disease Diagnostics Market Drivers
Figure 21. Rare Disease Diagnostics Market Restraints
Figure 22. Rare Disease Diagnostics Market Trends
Figure 23. Retrophin Recent Developments and Future Plans
Figure 24. 3billion Recent Developments and Future Plans
Figure 25. 23andMe Recent Developments and Future Plans
Figure 26. QIAGEN Recent Developments and Future Plans
Figure 27. Illumina Recent Developments and Future Plans
Figure 28. PerkinElmer Recent Developments and Future Plans
Figure 29. Strand Life Sciences Recent Developments and Future Plans
Figure 30. Global Rare Disease Diagnostics Revenue Share by Players in 2020
Figure 31. Rare Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Rare Disease Diagnostics Revenue Market Share in 2020
Figure 33. Global Top 10 Players Rare Disease Diagnostics Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Rare Disease Diagnostics Revenue Share by Type in 2020
Figure 36. Global Rare Disease Diagnostics Market Share Forecast by Type (2021-2026)
Figure 37. Global Rare Disease Diagnostics Revenue Share by Application in 2020
Figure 38. Global Rare Disease Diagnostics Market Share Forecast by Application (2021-2026)
Figure 39. North America Rare Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 40. North America Rare Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 41. North America Rare Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 42. United States Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Rare Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 46. Europe Rare Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 47. Europe Rare Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 48. Germany Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Rare Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Rare Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Rare Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 56. China Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Rare Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 63. South America Rare Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 64. South America Rare Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Rare Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Rare Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Rare Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Rare Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の希少神経変性疾患治療市場 2021：企業別、地域別、種類・用途別 The Rare Neurodegenerative Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 世界の呼吸器疾患検査/診断市場 2021：企業別、地域別、種類・用途別 The Respiratory Disease Testing/Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のIVD用PCR感染症検査市場 2021：企業別、地域別、種類・用途別 The Infectious Disease Testing Using PCR for IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の疾病検査用口腔液収集チューブ市場 2021：企業別、地域別、種類・用途別 The Oral Fluid Collection Tubes for Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界の病気リスク・健康DNA検査市場 2021：企業別、地域別、種類・用途別 The Disease Risk and Health DNA Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…